Dry Eye Disease

Last month, I outlined my philosophy for treating not just dry eye disease, or DED, but pretty much everything there is to be treated in eye care.

We’re still in the first quarter of the insurance plan year.

Twice-daily cyclosporine ophthalmic emulsion 0.09% significantly improved signs of dry eye disease in patients who were inadequately controlled with cyclosporine ophthalmic emulsion 0.05%, according to a study presented at SECO 2025.

Hormonal changes can cause physiological and pathological changes in the eye, and eye care providers should monitor pregnant patients well past delivery, according to a literature review published in Clinical and Experimental Optometry.

ORLANDO — In this Healio Video Perspective from Telling It Like It Is, Jai G. Parekh, MD, MBA, chief commercial officer of Nordic Pharma, Eye Care U.S., discusses the benefits of Lacrifill for dry eye disease.

OK, I know what you are thinking. Am I not the same guy who has been spouting off about our new dry eye world of “and,” not “either/or?” It is only a little more than a year in this new treatment paradigm, and I am already changing my tune?

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Riad Sherif, MD, CEO of Oculis, discusses data on OCS-05 for the treatment of acute optic neuritis.

KOLOA, Hawaii — Aggressive treatment before ocular surgery helps avoid postoperative issues with visual quality in patients with dry eye disease, according to a speaker at Hawaiian Eye 2025.

KOLOA, Hawaii — Building a dry eye clinic presents a practice with new opportunities for growth, according to a speaker at Hawaiian Eye 2025.